Medpedia

Intra-arterial Chemotherapy for Children With Retinoblastoma

Status: Not yet recruiting

Dates: 01/01/2011 to Present

Participants: 10

Phase: Phase 1/Phase 2

Study type: Interventional

Ages eligible for study: 0 - 10

Accepts healthy volunteers: No

Inclusion Criteria:
-  Children with retinoblastoma in a single remaining eye with useful vision
Exclusion Criteria:
-  None

Drug: Intra-arterial injection of melphalan

Injection of 5 milligrams of melphalan into the ophthalmic artery once every 3 weeks for a total of 6 courses
Drug: Injection of melphalan into the ophthalmic artery

Injection of 5 milligrams of melphalan into the ophthalmic artery in an eye affected by retinoblastoma

Michael Weintraub, MD

michaelw@hadassah.org.il

Jacob Pe'er, MD

There are no comments for this clinical trial.

Have you participated in this clinical trial? Let us know how it went.

You must be signed in to post a comment. - Sign in now

First Received on 05/19/2009 Last Updated on 05/26/2010